# GNRH1

## Overview
The GNRH1 gene encodes the gonadotropin-releasing hormone 1 (GnRH1), a pivotal neuropeptide in the regulation of the hypothalamic-pituitary-gonadal axis, which is essential for reproductive development and function. GnRH1 is synthesized in the hypothalamus and plays a crucial role in stimulating the anterior pituitary gland to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby influencing gonadal function and the production of gametes and steroid hormones (Hoffmann2018Regulation; Stamatiades2018Gonadotropin). The protein is a decapeptide, characterized by its specific amino acid composition and secondary structure, and functions as a monomer without a quaternary structure (Zhang2015Molecular; Fernald1999GonadotropinReleasing). The expression and function of GNRH1 are tightly regulated by various transcriptional and post-transcriptional mechanisms, and disruptions in its expression can lead to reproductive disorders such as hypogonadotropic hypogonadism (Zhao2008Heterogeneous; Huang2016A). Understanding the molecular and genetic basis of GNRH1 is crucial for elucidating its role in reproductive health and disease.

## Structure
The GNRH1 gene encodes the gonadotropin-releasing hormone (GnRH), a decapeptide involved in the regulation of reproductive hormones. The primary structure of GnRH consists of 92 amino acids, with a molecular weight of 10,205.6 Da and a theoretical isoelectric point of 5.67 (Zhang2015Molecular). The protein is characterized by a high proportion of glutamic acid (13.0%) and low proportions of aspartic acid and tryptophan (1.1%) (Zhang2015Molecular). 

The secondary structure of GnRH includes approximately 23.08% α-helix, 10.92% β-extended structures, and 66.0% random coils (Zhang2015Molecular). The protein is synthesized on ribosomes on the endoplasmic reticulum and is secreted outside the cell, with a signal peptide located between amino acids 1 to 23 (Zhang2015Molecular). 

GnRH typically functions as a monomer, indicating a lack of quaternary structure (Fernald1999GonadotropinReleasing). The protein is classified as unstable with an instability index of 50.05, and it has an aliphatic index of 84.89 and a grand average of hydropathicity of -0.403 (Zhang2015Molecular). No specific conservative domains have been identified in the protein (Zhang2015Molecular).

## Function
The GNRH1 gene encodes the gonadotropin-releasing hormone (GnRH), a neuropeptide crucial for the regulation of the hypothalamic-pituitary-gonadal axis, which is essential for normal reproductive development and function. GnRH is synthesized in a specific population of neurons in the hypothalamus and is released in a pulsatile manner. This pulsatile release is vital for its function, as it stimulates the anterior pituitary gland to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (Hoffmann2018Regulation; Stamatiades2018Gonadotropin).

These hormones, in turn, act on the gonads to promote the production of gametes and steroid hormones, thereby regulating processes such as puberty, the menstrual cycle, and fertility (Huang2016A). The expression of GnRH is tightly regulated by transcription factors and noncoding RNAs, which ensure its precise control in the hypothalamus (Hoffmann2018Regulation; Huang2016A). Disruptions in GNRH1 expression can lead to reproductive disorders, highlighting its critical role in maintaining reproductive health (Huang2016A). The gene's expression is also influenced by chromatin structure and histone modifications, which affect transcription factor access and gene transcription (Hoffmann2018Regulation).

## Clinical Significance
Mutations in the GNRH1 gene are associated with various forms of hypogonadotropic hypogonadism, a condition characterized by insufficient production or action of gonadotropin-releasing hormone (GnRH), leading to reproductive issues. Congenital hypogonadotropic hypogonadism (CHH) can result from mutations such as the p.R31C variant, which is linked to a reduced ability of GnRH to bind and activate its receptors, causing lower binding affinity and signaling activity (Stuckey2023Digenic; Maione2013R31C). This mutation has been identified in multiple individuals and families, suggesting it may be a mutational hotspot (Maione2013R31C).

The p.R31H mutation in GNRH1 is associated with normosmic CHH, characterized by severe symptoms like cryptorchidism and microphallus, and is linked to a complete loss of GnRH activity (Brachet2020Homozygous). Other mutations, such as frameshift mutations, can lead to idiopathic hypogonadotropic hypogonadism (nIHH), with severe phenotypes including microphallus and cryptorchidism (Chan2009GNRH1).

Digenic inheritance patterns have been observed, where mutations in GNRH1 and other genes like AMHR2 contribute to CHH, indicating a complex genetic basis for these conditions (Stuckey2023Digenic). These findings underscore the critical role of GNRH1 in reproductive development and its impact on fertility.

## Interactions
GNRH1, which encodes the gonadotropin-releasing hormone (GnRH), is involved in several interactions with proteins and nucleic acids that regulate its function and expression. The transcription of the GNRH1 gene is repressed by heterogeneous nuclear ribonucleoproteins (hnRNP-A/B and hnRNP-G), which bind to the upstream promoter region of the gene. These proteins act as transcriptional repressors by down-regulating GNRH1 mRNA levels, as demonstrated in studies using immortalized mouse GT1-7 cells (Zhao2008Heterogeneous).

In terms of post-transcriptional regulation, MKRN3 mediates the ubiquitination of poly(A)-binding proteins (PABPC1 and PABPC4), which affects the stability and translation of GNRH1 mRNA. This ubiquitination process destabilizes GNRH1 mRNA, leading to its down-regulation in the hypothalamus. The interaction between MKRN3 and PABPC1 is crucial for regulating the post-transcriptional stability and translation of GNRH1 mRNA, which is significant for the initiation of mammalian puberty (Li2021MKRN3mediated).

These interactions highlight the complex regulatory mechanisms controlling GNRH1 expression, involving both transcriptional repression and post-transcriptional modifications, which are essential for its role in reproductive hormone regulation.


## References


[1. (Hoffmann2018Regulation) Hanne M. Hoffmann and Pamela L. Mellon. Regulation of gnrh gene expression. March 2018. URL: http://dx.doi.org/10.1002/9781119233275.CH5, doi:10.1002/9781119233275.ch5. This article has 8 citations.](https://doi.org/10.1002/9781119233275.CH5)

[2. (Stuckey2023Digenic) Bronwyn G. A. Stuckey, Timothy W. Jones, Bryan K. Ward, and Scott G. Wilson. Digenic congenital hypogonadotropic hypogonadism due to heterozygous gnrh1 p.r31c and amhr2 p.g445_l453del variants. Genes, 14(6):1204, May 2023. URL: http://dx.doi.org/10.3390/genes14061204, doi:10.3390/genes14061204. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14061204)

[3. (Stamatiades2018Gonadotropin) George A. Stamatiades and Ursula B. Kaiser. Gonadotropin regulation by pulsatile gnrh: signaling and gene expression. Molecular and Cellular Endocrinology, 463:131–141, March 2018. URL: http://dx.doi.org/10.1016/j.mce.2017.10.015, doi:10.1016/j.mce.2017.10.015. This article has 159 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2017.10.015)

[4. (Brachet2020Homozygous) Cécile Brachet, Caroline Gernay, Emese Boros, Julie Soblet, Catheline Vilain, and Claudine Heinrichs. Homozygous p.r31h gnrh1 mutation and normosmic congenital hypogonadotropic hypogonadism in a patient and self-limited delayed puberty in his relatives. Journal of Pediatric Endocrinology and Metabolism, 33(9):1237–1240, August 2020. URL: http://dx.doi.org/10.1515/jpem-2020-0207, doi:10.1515/jpem-2020-0207. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/jpem-2020-0207)

[5. (Zhao2008Heterogeneous) Sheng Zhao, Wayne J. Korzan, Chun-Chun Chen, and Russell D. Fernald. Heterogeneous nuclear ribonucleoprotein a/b and g inhibits the transcription of gonadotropin-releasing-hormone 1. Molecular and Cellular Neuroscience, 37(1):69–84, January 2008. URL: http://dx.doi.org/10.1016/j.mcn.2007.08.015, doi:10.1016/j.mcn.2007.08.015. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2007.08.015)

[6. (Chan2009GNRH1) Yee-Ming Chan, Adelaide de Guillebon, Mariarosaria Lang-Muritano, Lacey Plummer, Felecia Cerrato, Sarah Tsiaras, Ariana Gaspert, Hélène B. Lavoie, Ching-Hui Wu, William F. Crowley, John K. Amory, Nelly Pitteloud, and Stephanie B. Seminara. Gnrh1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences, 106(28):11703–11708, July 2009. URL: http://dx.doi.org/10.1073/pnas.0903449106, doi:10.1073/pnas.0903449106. This article has 147 citations.](https://doi.org/10.1073/pnas.0903449106)

[7. (Li2021MKRN3mediated) Chuanyin Li, Tianting Han, Qingrun Li, Menghuan Zhang, Rong Guo, Yun Yang, Wenli Lu, Zhengwei Li, Chao Peng, Ping Wu, Xiaoxu Tian, Qinqin Wang, Yuexiang Wang, Vincent Zhou, Ziyan Han, Hecheng Li, Feng Wang, and Ronggui Hu. Mkrn3-mediated ubiquitination of poly(a)-binding proteins modulates the stability and translation of gnrh1 mrna in mammalian puberty. Nucleic Acids Research, 49(7):3796–3813, March 2021. URL: http://dx.doi.org/10.1093/nar/gkab155, doi:10.1093/nar/gkab155. This article has 49 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkab155)

[8. (Zhang2015Molecular) T. Zhang, G.X. Zhang, K.P. Han, Y. Tang, J.Y. Wang, Q.C. Fan, X.S. Chen, Y. Wei, and Y.J. Wang. Molecular cloning and characterization, and prokaryotic expression of the gnrh1 gene obtained from jinghai yellow chicken. Genetics and Molecular Research, 14(1):2831–2849, 2015. URL: http://dx.doi.org/10.4238/2015.march.31.14, doi:10.4238/2015.march.31.14. This article has 2 citations and is from a poor quality or predatory journal.](https://doi.org/10.4238/2015.march.31.14)

[9. (Maione2013R31C) Luigi Maione, Frederique Albarel, Philippe Bouchard, Megan Gallant, Colleen A. Flanagan, Regis Bobe, Joelle Cohen-Tannoudji, Rosario Pivonello, Annamaria Colao, Thierry Brue, Robert P. Millar, Marc Lombes, Jacques Young, Anne Guiochon-Mantel, and Jerome Bouligand. R31c gnrh1 mutation and congenital hypogonadotropic hypogonadism. PLoS ONE, 8(7):e69616, July 2013. URL: http://dx.doi.org/10.1371/journal.pone.0069616, doi:10.1371/journal.pone.0069616. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0069616)

[10. (Fernald1999GonadotropinReleasing) Russell D. Fernald and Richard B. White. Gonadotropin-releasing hormone genes: phylogeny, structure, and functions. Frontiers in Neuroendocrinology, 20(3):224–240, July 1999. URL: http://dx.doi.org/10.1006/frne.1999.0181, doi:10.1006/frne.1999.0181. This article has 229 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/frne.1999.0181)

[11. (Huang2016A) Polly P. Huang, Liza E. Brusman, Anita K. Iyer, Nicholas J. G. Webster, and Pamela L. Mellon. A novel gonadotropin-releasing hormone 1 (gnrh1) enhancer-derived noncoding rna regulates gnrh1 gene expression in gnrh neuronal cell models. PLOS ONE, 11(7):e0158597, July 2016. URL: http://dx.doi.org/10.1371/journal.pone.0158597, doi:10.1371/journal.pone.0158597. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0158597)